Context Therapeutics Inc. (CNTX) Misses Q3 EPS by 17c

Context Therapeutics Inc. (NASDAQ: CNTX) reported Q3 EPS of ($0.22), $0.17 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.

You May Also Be Interested In

• US Eyes 7.5% China Overcapacity Tariffs Before Xi-Trump Talks - Bloomberg
• X Financial (XYF) Tops Q2 EPS by 438c
• Strategy (MSTR) call put ratio 2.1 calls to 1 put with a focus on August 28 weekly calls as share price up 5.1%